Foresite Capital Management VI LLC
Top Portfolio Positions
17 positions ·
$460,271,341 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| CGON |
CG Oncology, Inc.
Healthcare
|
2,221,474 | $150,349,360 | 32.67% | |
| ALMS |
Alumis Inc.
Healthcare
|
4,247,670 | $93,576,170 | 20.33% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
1,364,019 | $54,178,834 | 11.77% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
1,831,233 | $26,790,938 | 5.82% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
1,209,971 | $23,231,443 | 5.05% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
525,000 | $17,760,750 | 3.86% | |
| VSTM |
Verastem, Inc.
Healthcare
|
3,146,631 | $16,677,144 | 3.62% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
146,332 | $12,187,992 | 2.65% | |
| NERV |
Minerva Neurosciences, Inc.
Healthcare
|
1,986,600 | $11,969,265 | 2.60% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
315,913 | $10,020,760 | 2.18% |
Portfolio Trend
6 quarters · across all stocks
Holdings in KYMR
Shares Held
Position Value (USD)
6 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,187,992 | 146,332 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,386,092 | 146,332 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,282,391 | 146,332 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,385,928 | 146,332 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,005,106 | 146,332 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,886,936 | 146,332 | Shares | Sole | 2025-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||